Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry

Health activists and scientists in Europe met to develop strategies to build regional public pharmaceutical infrastructure as pandemic lessons seems lost on governments and producers

A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits

In a bid for transparency, health activists and civil society in South Africa have published the details of COVID-19 vaccine contracts between pharmaceutical giants and government. This follows a Pretoria High Court order instructing the Department of Health to disclose the contracts and proceedings of meetings pertaining to the procurement of vaccine doses

Cuba was prohibited from accessing spare parts for their only oxygen plant as well as importing medical oxygen due to the blockade, as COVID-19 ran rampant

The new government begins work with billions less for the sector and faces the challenge of rebuilding primary care

Immunologist Dr. Satyajit Rath and NewsClick’s Editor-in-Chief Prabir Purkayastha discuss reports of new COVID-19 variants and what it means for public health authorities across the world

Cuba–Italy collaboration on COVID-19 moves forward as memorandum for production of vaccines is signed between Finlay Institute of Vaccines and Italian biotech company

Cuban scientists have announced the next stage of research on NeuralCIM, a neuroprotective drug for Alzheimer’s disease and other forms of dementia

The West cannot keep infectious diseases out any more than claim victory over them. Microbes evolve and strike back unless sporadic outbreaks are tackled wherever they occur

George Poe Williams from the National Health Workers Union of Liberia comments on the recent outcome of the WTO Ministerial Conference and the disappointment this has caused among health workers

Obstruction by pharmaceutical companies from the Global North and misuse of monopoly privileges continue to slow down research into new vaccines and medicines, with disastrous effects for people’s health in the Global South. Discussions at the 75th World Health Assembly did little to address this